The dopaminergic response in multiple system atrophy.

Fifteen of 23 pathologically confirmed cases of multiple system atrophy (MSA) showed some initial response to levodopa and eight of these remained at least partially responsive at the time of death. Eleven developed motor oscillations, and drug-induced dyskinesias, often involving the face and jaw, were also seen in 11 cases. Acute levodopa and apomorphine challenges were administered to 11 patients with clinical MSA who were considered levodopa responsive. A short duration relatively small amplitude response with associated dyskinesias occurred in six and a further three developed dyskinesias without any motor response. Following levodopa withdrawal, a delayed deterioration occurred after three to six days in six patients, five of whom had shown no short duration motor response to the acute challenges. The occurrence of levodopa-induced dyskinesias without a concomitant motor response and delayed deterioration several days after levodopa withdrawal may be more typical of patients with MSA than Parkinson's disease.

[1]  Y. Kuroiwa,et al.  Failed levodopa therapy in striato-nigral degeneration. , 1971, Lancet.

[2]  T. Chase,et al.  Pathogenesis of dyskinesias in parkinson's disease , 1989, Annals of neurology.

[3]  A. Rajput,et al.  Levodopa efficacy and pathological basis of Parkinson syndrome. , 1990, Clinical neuropharmacology.

[4]  A. Koeppen,et al.  Striatonigral degeneration , 2004, Acta Neuropathologica.

[5]  C. Goetz,et al.  The pharmacology of olivopontocerebellar atrophy. , 1984, Advances in neurology.

[6]  A. Rajput,et al.  Striatonigral degeneration response to levodopa therapy. , 1972, Journal of the neurological sciences.

[7]  C. Tanner,et al.  Weekly drug holiday in Parkinson disease , 1981, Neurology.

[8]  J. Kepes,et al.  Parkinsonism due to a basal ganglia lacunar state , 1990, Neurology.

[9]  Ward Cd,et al.  Research diagnostic criteria for Parkinson's disease. , 1990 .

[10]  C. Marsden,et al.  Early onset of the "on-off" phenomenon in children with symptomatic Parkinsonism. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[11]  A. Gosset,et al.  [Striatonigral degeneration associated with olivopontocerebellar atrophy. Anatomo-clinical study of 3 cases. Nosologic discussion]. , 1983, Revue neurologique.

[12]  A. Lees,et al.  Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes , 1990, The Lancet.

[13]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[14]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[15]  M. Muenter,et al.  L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. , 1971, Mayo Clinic proceedings.

[16]  J. Trotter Striatonigral degeneration, Alzheimer's disease, and inflammatory changes , 1973, Neurology.

[17]  R D ADAMS,et al.  STRIATO-NIGRAL DEGENERATION. , 1964, Journal of neuropathology and experimental neurology.

[18]  A. Lees,et al.  Striatonigral degeneration. A clinicopathological study. , 1990, Brain : a journal of neurology.

[19]  W. Koller Alternate day levodopa therapy in parkinsonism , 1982, Neurology.

[20]  A. Lang,et al.  Levodopa dose‐related fluctuations in presumed olivopontocerebellar atrophy , 1986, Movement disorders : official journal of the Movement Disorder Society.

[21]  A. J. Lees,et al.  Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[22]  A. Barbeau,et al.  Six‐year results of treatment with levodopa plus benzerazide in Parkinson's disease , 1976, Neurology.

[23]  C. Ward,et al.  Research diagnostic criteria for Parkinson's disease. , 1990, Advances in neurology.

[24]  S. Yorifuji,et al.  Dopamine metabolism in the central nervous system after discontinuation of l-dopa therapy in patients with Parkinson disease , 1984, Journal of the Neurological Sciences.

[25]  J. Sharpe,et al.  Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation. , 1973, Journal of the neurological sciences.

[26]  A. Lees,et al.  Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.